130 related articles for article (PubMed ID: 16847382)
21. POSSUM predicts survival in patients with unresectable pancreatic cancer.
de Castro SM; Houwert JT; Lagard SM; Busch OR; van Gulik TM; Gouma DJ
Dig Surg; 2009; 26(1):75-9. PubMed ID: 19169034
[TBL] [Abstract][Full Text] [Related]
22. Inflammation-based prognostic system predicts survival after surgery for stage IV colorectal cancer.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
Am J Surg; 2013 Jan; 205(1):22-8. PubMed ID: 23116639
[TBL] [Abstract][Full Text] [Related]
23. Predicting factors for survival of patients with unresectable pancreatic cancer: a management guideline.
Fujino Y; Suzuki Y; Ajiki T; Tanioka Y; Ku Y; Kuroda Y
Hepatogastroenterology; 2003; 50(49):250-3. PubMed ID: 12630033
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer.
Al Murri AM; Bartlett JM; Canney PA; Doughty JC; Wilson C; McMillan DC
Br J Cancer; 2006 Jan; 94(2):227-30. PubMed ID: 16404432
[TBL] [Abstract][Full Text] [Related]
25. [Surgical palliation for pancreatic cancer. The 25-year experience of a single reference centre].
Popiela T; Kedra B; Sierzega M; Kubisz A
Zentralbl Chir; 2002 Nov; 127(11):965-70. PubMed ID: 12476370
[TBL] [Abstract][Full Text] [Related]
26. The prognostic effect of clinical staging in pancreatic adenocarcinoma.
Morganti AG; Brizi MG; Macchia G; Sallustio G; Costamagna G; Alfieri S; Mattiucci GC; Valentini V; Natale L; Deodato F; Mutignani M; Doglietto GB; Cellini N
Ann Surg Oncol; 2005 Feb; 12(2):145-51. PubMed ID: 15827795
[TBL] [Abstract][Full Text] [Related]
27. Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer.
Sharma R; Zucknick M; London R; Kacevska M; Liddle C; Clarke SJ
Clin Colorectal Cancer; 2008 Sep; 7(5):331-7. PubMed ID: 18794066
[TBL] [Abstract][Full Text] [Related]
28. Prospective study of the role of inflammation in renal cancer.
Qayyum T; McArdle PA; Lamb GW; Going JJ; Orange C; Seywright M; Horgan PG; Oades G; Aitchison MA; Edwards J
Urol Int; 2012; 88(3):277-81. PubMed ID: 22377628
[TBL] [Abstract][Full Text] [Related]
29. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
[TBL] [Abstract][Full Text] [Related]
30. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
Ishizuka M; Nagata H; Takagi K; Kubota K
Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907
[TBL] [Abstract][Full Text] [Related]
31. A comparison of POSSUM and GPS models in the prediction of post-operative outcome in patients undergoing oesophago-gastric cancer resection.
Dutta S; Al-Mrabt NM; Fullarton GM; Horgan PG; McMillan DC
Ann Surg Oncol; 2011 Oct; 18(10):2808-17. PubMed ID: 21431986
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of predictive value of Okuda, TNM, CLIP and JIS staging systems for hepatocellular carcinoma patients].
Lee SW; Han SY; Kim KT; Baek YH; Koh IY; Kim BH; Park EH; Jang JS; Roh MH; Choi JC
Korean J Hepatol; 2007 Jun; 13(2):196-207. PubMed ID: 17585193
[TBL] [Abstract][Full Text] [Related]
33. Improved survival with adjuvant external-beam radiation therapy in lymph node-negative pancreatic cancer: a United States population-based assessment.
Artinyan A; Hellan M; Mojica-Manosa P; Chen YJ; Pezner R; Ellenhorn JD; Kim J
Cancer; 2008 Jan; 112(1):34-42. PubMed ID: 18000805
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.
Papadoniou N; Kosmas C; Gennatas K; Polyzos A; Mouratidou D; Skopelitis E; Tzivras M; Sougioultzis S; Papastratis G; Karatzas G; Papalambros E; Tsavaris N
Anticancer Res; 2008; 28(1B):543-9. PubMed ID: 18383900
[TBL] [Abstract][Full Text] [Related]
35. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer.
McMillan DC; Crozier JE; Canna K; Angerson WJ; McArdle CS
Int J Colorectal Dis; 2007 Aug; 22(8):881-6. PubMed ID: 17245566
[TBL] [Abstract][Full Text] [Related]
37. Survival analysis of 254 patients after manifestation of spinal metastases: evaluation of seven preoperative scoring systems.
Wibmer C; Leithner A; Hofmann G; Clar H; Kapitan M; Berghold A; Windhager R
Spine (Phila Pa 1976); 2011 Nov; 36(23):1977-86. PubMed ID: 21304424
[TBL] [Abstract][Full Text] [Related]
38. Pre-operative predictors of short-term survival after pancreatic cancer resection.
Takeuchi M; Kondo S; Sugiura H; Katoh H
Hepatogastroenterology; 1998; 45(24):2399-403. PubMed ID: 9951931
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer.
Lundin J; Nordling S; von Boguslawsky K; Roberts PJ; Haglund C
Anticancer Res; 1995; 15(6B):2659-68. PubMed ID: 8669843
[TBL] [Abstract][Full Text] [Related]
40. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients.
Bilimoria KY; Talamonti MS; Tomlinson JS; Stewart AK; Winchester DP; Ko CY; Bentrem DJ
Ann Surg; 2008 Mar; 247(3):490-500. PubMed ID: 18376195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
